These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32221826)

  • 1. Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand.
    Sukkha S; Rattanavipanon W; Chamroenwit B; Sanganurak M; Nathisuwan S; Chaikledkaew U; Kongwatcharapong J
    Int J Clin Pharm; 2020 Apr; 42(2):610-616. PubMed ID: 32221826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
    Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
    Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
    Muñoz-Pichuante D; Villa-Zapata L
    J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
    Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
    Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacy services in an Iranian teaching hospital: a descriptive study.
    Dashti-Khavidaki S; Khalili H; Hamishekar H; Shahverdi S
    Pharm World Sci; 2009 Dec; 31(6):696-700. PubMed ID: 19806466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
    Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
    J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of pharmacists’ antibiotic dosing recommendations for sustained low-efficiency dialysis.
    Mei JP; Ali-Moghaddam A; Mueller BA
    Int J Clin Pharm; 2016 Feb; 38(1):127-34. PubMed ID: 26499505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost savings and avoidance from clinical interventions.
    Mutnick AH; Sterba KJ; Peroutka JA; Sloan NE; Beltz EA; Sorenson MK
    Am J Health Syst Pharm; 1997 Feb; 54(4):392-6. PubMed ID: 9043561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of clinical pharmacist recommendations and services at a University Hospital in Yemen.
    Kubas MA; Halboup AM
    Int J Clin Pharm; 2020 Feb; 42(1):51-56. PubMed ID: 31713107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pharmacists' interventions on physicians' decision of a knowledge-based renal dosage adjustment system.
    Choi KS; Lee E; Rhie SJ
    Int J Clin Pharm; 2019 Apr; 41(2):424-433. PubMed ID: 30864079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
    Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
    Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
    Hamblin S; Rumbaugh K; Miller R
    J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' acceptance of pharmacists' interventions in daily hospital practice.
    Zaal RJ; den Haak EW; Andrinopoulou ER; van Gelder T; Vulto AG; van den Bemt PMLA
    Int J Clin Pharm; 2020 Feb; 42(1):141-149. PubMed ID: 32026348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital.
    Claus BO; Vandeputte FM; Robays H
    Int J Clin Pharm; 2012 Oct; 34(5):773-8. PubMed ID: 22810891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized physician order entry system combined with on-ward pharmacist: analysis of pharmacists' interventions.
    Bedouch P; Tessier A; Baudrant M; Labarere J; Foroni L; Calop J; Bosson JL; Allenet B
    J Eval Clin Pract; 2012 Aug; 18(4):911-8. PubMed ID: 21689216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.
    Chen CC; Hsiao FY; Shen LJ; Wu CC
    Medicine (Baltimore); 2017 Aug; 96(34):e7883. PubMed ID: 28834903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review.
    Al Raiisi F; Stewart D; Fernandez-Llimos F; Salgado TM; Mohamed MF; Cunningham S
    Int J Clin Pharm; 2019 Jun; 41(3):630-666. PubMed ID: 30963447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.